The post 74% of institutional investors plan to add to crypto in 2026 appeared on BitcoinEthereumNews.com. A Coinbase–EY survey of 351 institutions finds 74% expectThe post 74% of institutional investors plan to add to crypto in 2026 appeared on BitcoinEthereumNews.com. A Coinbase–EY survey of 351 institutions finds 74% expect

74% of institutional investors plan to add to crypto in 2026

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

A Coinbase–EY survey of 351 institutions finds 74% expect crypto prices to rise and 73% plan to increase allocations, with stablecoins and tokenisation driving the next wave.

Summary

  • A January 2026 Coinbase and EY-Parthenon survey of 351 institutions found 74% expect crypto prices to rise and 73% plan to increase allocations this year.
  • Respondents now favour ETPs and other regulated vehicles for exposure, while 83% already use or plan to use stablecoins and view the GENIUS Act as a key catalyst.
  • Sixty-three percent are interested in tokenised assets and 61% see tokenisation reshaping market structure, even as recent volatility pushes nearly half to tighten risk and liquidity management.

Despite a brutal Wednesday for digital asset prices — Bitcoin (BTC) sliding to $72,300 and a broad market selloff driven by Middle East conflict and hot inflation data — a major new institutional survey published this week tells a strikingly different story about where the smart money is heading. A joint report by Coinbase and EY-Parthenon, based on a survey of 351 institutional investors conducted in January 2026, found that 74% of respondents expect cryptocurrency prices to rise in the future, while 73% plan to increase their digital asset allocation before the end of the year.​

The findings represent a significant institutionalisation of crypto conviction. The survey, which polled decision-makers at asset managers, hedge funds, private banks, venture capital firms, family offices, and asset owners globally, found that exchange-traded products (ETPs) and other regulated instruments have now become the preferred exposure vehicle for two-thirds of respondents. That shift — from direct on-chain holdings toward regulated wrappers — reflects both the maturing product landscape and the compliance imperatives of institutional capital, following the landmark approval and uptake of spot Bitcoin and Ethereum ETFs in the U.S. over the past two years.

When asked about the primary obstacle to further institutional engagement, more than three-quarters of respondents pointed to market structure regulation as the issue requiring the most urgent clarification. This finding echoes the prior year’s survey, in which 52% of respondents named regulatory uncertainty as their top concern and 68% identified greater regulatory clarity as the single most important catalyst for the industry’s next growth phase.

The regulatory landscape has shifted materially since then. The GENIUS Act — signed into law by President Trump on July 18, 2025 — established the first comprehensive federal framework for payment stablecoins in the United States, introducing 1:1 reserve mandates, licensing requirements, and federal preemption over conflicting state regimes. The Office of the Comptroller of the Currency subsequently issued proposed implementing regulations in March 2026, with a public comment deadline of May 1. The survey’s findings suggest institutions are watching this process closely: 83% of respondents said they have used or plan to use stablecoins for payments and financial management, while 83% also said passage of the GENIUS Act would enhance financial institutions’ willingness to participate in the stablecoin market.

The appetite for tokenised assets is similarly broad. Sixty-three percent of respondents expressed interest in tokenised assets, and 61% expect tokenisation to have a significant impact on market structure — a finding consistent with the rapid growth of real-world asset (RWA) tokenisation across DeFi platforms, where Morpho alone saw RWA deposits grow from near zero to $400 million over the course of 2025.

Amid widespread bullishness, the survey also captured the scars of recent volatility. Nearly half of respondents — 49% — said that recent market fluctuations had led them to place greater emphasis on risk management, liquidity, and position control, rather than reducing their holdings outright. That distinction matters: institutional capital appears to be recalibrating its approach rather than retreating, a posture that may prove consequential as markets navigate the current geopolitical shock.​

The juxtaposition between Wednesday’s price action and the survey’s conclusions encapsulates the central tension facing institutional crypto allocators in 2026: near-term macro headwinds severe enough to test conviction, set against a structural adoption thesis that continues to broaden quarter by quarter.

Source: https://crypto.news/survey-74-of-institutional-investors-plan-to-add-to-crypto-in-2026/

Market Opportunity
RISE Logo
RISE Price(RISE)
$0.003031
$0.003031$0.003031
-1.01%
USD
RISE (RISE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Share
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Share
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26